The applicability of Twombly and Iqbal to pharmaceutical product liability litigation

Since the adoption of the Federal Rules of Civil Procedure, and similar state procedural rules, the threshold that plaintiffs must meet to survive a motion to dismiss for failure to state a claim has been very low. Two recent Supreme Court decisions dramatically change that requirement for plaintiffs and, while not returning to the pre-rules technical and formal requirements, make clear that mere conclusory allegations will no longer satisfy plaintiff's burden in pleading a claim for relief